Skip to main content
Equibles

Homestead Advisers Corp

Position in RPRX — Royalty Pharma plc

CIK 944804 Arlington, VA
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$92,921,558
+$13,625,134 QoQ
Shares Held
1,657,242
+0.3% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
2.31%
of 13F equity value
Holder Rank
#42
of 646 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Homestead Advisers Corp holds $101,557,390 across 6 Biotechnology names. RPRX ranks #1 (91.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
This page 		1,657,242 $92,921,558
2 PRAX
Praxis Precision Medicines, Inc.
 6,500 $2,176,135
3 KRYS
Krystal Biotech, Inc.
 5,500 $2,044,185
4 PCVX
Vaxcyte, Inc.
 34,400 $1,999,672
5 CYTK
Cytokinetics Inc
 23,200 $1,976,408
6 BBIO
BridgeBio Pharma, Inc.
 5,900 $439,432

All Filings in RPRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,921,558 1,657,242
2026-03-31 $79,296,424 1,653,042
2025-12-31 $64,588,382 1,671,542
2025-09-30 $67,118,083 1,902,440
2025-06-30 $69,878,023 1,939,440
2025-03-31 $60,116,388 1,931,140
2024-12-31 $49,263,381 1,931,140
2024-09-30 $52,566,780 1,858,140
2024-06-30 $49,046,617 1,859,940
2024-03-31 $57,476,439 1,892,540
2023-12-31 $37,796,218 1,345,540
2023-09-30 $36,450,105 1,343,040
2023-06-30 $40,639,509 1,322,040
2023-03-31 $47,391,700 1,315,340
2022-12-31 $53,104,604 1,343,740
2022-09-30 $53,975,401 1,343,340
2022-06-30 $56,608,541 1,346,540
2022-03-31 $52,461,198 1,346,540
2021-12-31 $54,496,469 1,367,540
2021-09-30 $41,844,337 1,157,840
2021-06-30 $29,522,637 720,240